IL6 and prostate carcinoma: Other data show that there is an inverse correlation between the expression of SOCS-3 and IL-6-induced phosphorylation of STAT3 in prostate cancer cells; furthermore, downregulation of SOCS-3 by a short interfering RNA approach resulted in inhibition of proliferation and an increased apoptotic rate [35].